Influence of patient characteristics on chimeric antigen receptor T cell therapy in B-cell acute lymphoblastic leukemia

Influence of patient characteristics on chimeric antigen receptor T cell therapy in B-cell acute lymphoblastic leukemia

CAR T therapy has some efficacy in the treatment of patients with refractory/relapsed B-cell acute lymphoblastic leukemia; however in some patients further relapse is encountered. Here, the authors conduct a Phase II clinical trial of a CD19 CAR T and demonstrate that patients with extramedullary di...

Full description

Bibliographic Details
Main Authors:	Furun An, Huiping Wang, Zhenyun Liu, Fan Wu, Jiakui Zhang, Qianshan Tao, Yingwei Li, Yuanyuan Shen, Yanjie Ruan, Qing Zhang, Ying Pan, Weiwei Zhu, Hui Qin, Yansheng Wang, Yongling Fu, Zhenqing Feng, Zhimin Zhai
Format:	Article
Language:	English
Published:	Nature Publishing Group 2020-11-01
Series:	Nature Communications
Online Access:	https://doi.org/10.1038/s41467-020-19774-x

Similar Items

Chimeric Antigen Receptor T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia
by: Ciprian Tomuleasa, et al.
Published: (2018-02-01)

Advances in the development of chimeric antigen receptor-T-cell therapy in B-cell acute lymphoblastic leukemia
by: Xian Zhang, et al.
Published: (2020-02-01)

Chimeric Antigen Receptor T-Cells in B-Acute Lymphoblastic Leukemia: State of the Art and Future Directions
by: Uri Greenbaum, et al.
Published: (2020-08-01)

Dendritic cells decreased the concomitant expanded Tregs and Tregs related IL-35 in cytokine-induced killer cells and increased their cytotoxicity against leukemia cells.
by: Ying Pan, et al.
Published: (2014-01-01)

Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia
by: Guoqing Wei, et al.
Published: (2017-04-01)

Circulating Monocytic Myeloid-Derived Suppressor Cells Are Elevated and Associated with Poor Prognosis in Acute Myeloid Leukemia
by: Huiping Wang, et al.
Published: (2020-01-01)

Is there a role for B lymphocyte chimerism in the monitoring of B-acute lymphoblastic leukemia patients receiving allogeneic stem cell transplantation?
by: Yi-Ning Yang, et al.
Published: (2015-03-01)

Biomarkers for Chimeric Antigen Receptor T Cell Therapy in Acute Lymphoblastic Leukemia: Prospects for Personalized Management and Prognostic Prediction
by: Ruimin Hong, et al.
Published: (2021-02-01)

Leukemia-Initiating Cells in T-Cell Acute Lymphoblastic Leukemia
by: Shi Hao Tan, et al.
Published: (2017-09-01)

Chimeric Antigen Receptor T Cells Targeting NKG2D-Ligands Show Robust Efficacy Against Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia
by: Lina Driouk, et al.
Published: (2020-12-01)

MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
by: Elena Maino, et al.
Published: (2015-01-01)

Co-infusion of haplo-identical CD19-chimeric antigen receptor T cells and stem cells achieved full donor engraftment in refractory acute lymphoblastic leukemia
by: Bo Cai, et al.
Published: (2016-11-01)

Successful treatment of relapsed acute B-cell lymphoblastic leukemia with CD20/CD22 bispecific chimeric antigen receptor T-cell therapy
by: Zuyu Liang, et al.
Published: (2020-12-01)

How to Combine the Two Landmark Treatment Methods—Allogeneic Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Together to Cure High-Risk B Cell Acute Lymphoblastic Leukemia?
by: Mingming Zhang, et al.
Published: (2020-12-01)

FEATURES OF IMMUNE CELLS IN ACUTE LYMPHOBLASTIC LEUKEMIA
by: O. V. Smirnova, et al.
Published: (2014-07-01)

Atypical immunophenotype of T-cell Acute Lymphoblastic Leukemia
by: Abhishek Purohit, et al.
Published: (2014-01-01)

Changes of peripheral blood immune cells in acute coronary syndrome
by: Chengxin Zhang, et al.
Published: (2019-05-01)

Elevated M-MDSCs in Circulation Are Indicative of Poor Prognosis in Diffuse Large B-Cell Lymphoma Patients
by: Zhitao Wang, et al.
Published: (2021-04-01)

Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia
by: Mingxue Fan, et al.
Published: (2017-08-01)

Complete remission in refractory acute lymphoblastic leukemia using blinatumomab after failure of response to CD‐19 chimeric antigen receptor T‐cell therapy
by: Francesco Paolo Tambaro, et al.
Published: (2020-09-01)

Extracorporeal cytokine removal in chimeric antigen receptor T-cell therapy associated cytokine release syndrome in patient with acute lymphoblastic leukemia. Case report
by: Antonina E. Shchekina, et al.
Published: (2021-07-01)

Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia
by: Yuan-Fang Liu, et al.
Published: (2016-06-01)

Low LEF1 expression is a biomarker of early T-cell precursor, an aggressive subtype of T-cell lymphoblastic leukemia.
by: Mei Wang, et al.
Published: (2020-01-01)

High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia
by: Stephan Müller, et al.
Published: (2020-01-01)

Overcoming Steroid Resistance in T Cell Acute Lymphoblastic Leukemia.
by: Steven Goossens, et al.
Published: (2016-12-01)

Cytologic Phenotypes of B-Cell Acute Lymphoblastic Leukemia-
by: Ramyar Asghar, et al.
Published: (2009-06-01)

Myeloid/T-cell acute lymphoblastic leukemia in children and adults
by: Sabina Chiaretti, et al.
Published: (2011-06-01)

Facts and Challenges in Immunotherapy for T-cell Acute Lymphoblastic Leukemia
by: Fátima Bayón-Calderón, et al.
Published: (2020-10-01)

Aberrant Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia
by: Deborah Bongiovanni, et al.
Published: (2017-09-01)

Identification of Interconnected Markers for T-Cell Acute Lymphoblastic Leukemia
by: Emine Guven Maiorov, et al.
Published: (2013-01-01)

Chloroma in a child with T-cell acute lymphoblastic leukemia
by: Anirban Mandal, et al.
Published: (2017-01-01)

Monitoring of T-cell acute lymphoblastic leukemia by flow cytometry
by: Janeliūnienė Miglė, et al.
Published: (2010-12-01)

T-Cell Acute Lymphoblastic Leukemia: Biomarkers and Their Clinical Usefulness
by: Valentina Bardelli, et al.
Published: (2021-07-01)

A case of B-cell lymphoblastic leukemia cutis flaring following CAR T-cell therapy in a patient with refractory acute lymphoblastic leukemia
by: Pranav Puri, BA, et al.
Published: (2021-02-01)

Function of SLC7A7 in T-Cell Acute Lymphoblastic Leukemia
by: Xiaohui Ji, et al.
Published: (2018-07-01)

Leukemia cutis: An unusual presentation of acute lymphoblastic leukemia in a child
by: Xia Jiang, et al.
Published: (2015-01-01)

Investigating CD99 Expression in Leukemia Propagating Cells in Childhood T Cell Acute Lymphoblastic Leukemia.
by: Charlotte V Cox, et al.
Published: (2016-01-01)

Clinical Utility of Droplet Digital PCR to Monitor BCR-ABL1 Transcripts of Patients With Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia Post-chimeric Antigen Receptor19/22 T-Cell Cocktail Therapy
by: Yuqi Guan, et al.
Published: (2021-04-01)

Infection Complications after Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin Lymphoma
by: Felix Korell, et al.
Published: (2021-04-01)

Case Report: Local Cytokine Release Syndrome in an Acute Lymphoblastic Leukemia Patient After Treatment With Chimeric Antigen Receptor T-Cell Therapy: A Possible Model, Literature Review and Perspective
by: Chengxin Luan, et al.
Published: (2021-07-01)